Insider Selling: Phreesia, Inc. (NYSE:PHR) General Counsel Sells 1,212 Shares of Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 1,212 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total transaction of $25,488.36. Following the completion of the transaction, the general counsel now owns 119,791 shares in the company, valued at $2,519,204.73. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Phreesia Price Performance

Shares of NYSE:PHR opened at $19.80 on Friday. The firm has a market cap of $1.14 billion, a price-to-earnings ratio of -11.00 and a beta of 0.93. The firm has a fifty day moving average price of $23.30 and a 200 day moving average price of $22.41. Phreesia, Inc. has a fifty-two week low of $12.05 and a fifty-two week high of $29.16. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.77 and a current ratio of 1.77.

Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.06. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. The firm had revenue of $102.12 million for the quarter, compared to analysts’ expectations of $101.76 million. As a group, sell-side analysts expect that Phreesia, Inc. will post -1.23 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a report on Thursday, September 5th. Truist Financial lifted their price objective on Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, September 6th. Royal Bank of Canada reissued a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a report on Friday, September 27th. Needham & Company LLC reaffirmed a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Thursday, September 5th. Finally, KeyCorp dropped their price target on shares of Phreesia from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, July 11th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $29.42.

Institutional Trading of Phreesia

Several hedge funds have recently modified their holdings of PHR. Trust Point Inc. grew its holdings in shares of Phreesia by 3.5% in the third quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock valued at $408,000 after purchasing an additional 607 shares in the last quarter. Ensign Peak Advisors Inc grew its stake in shares of Phreesia by 3.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after buying an additional 700 shares in the last quarter. ProShare Advisors LLC increased its holdings in shares of Phreesia by 8.6% in the 1st quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock worth $228,000 after buying an additional 751 shares during the last quarter. Rhumbline Advisers raised its position in shares of Phreesia by 1.0% during the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after buying an additional 853 shares in the last quarter. Finally, Swiss National Bank lifted its holdings in shares of Phreesia by 1.0% in the 1st quarter. Swiss National Bank now owns 104,300 shares of the company’s stock valued at $2,496,000 after acquiring an additional 1,000 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.